{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:39:58Z","timestamp":1794947998224,"version":"4.9.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Doctoral Innovation Project of the First Affiliated\u00a0Hospital of Chongqing Medical University","award":["CYYY-BSYJSCXXM-202329"],"award-info":[{"award-number":["CYYY-BSYJSCXXM-202329"]}]},{"name":"Key Joint project of Chongqing Health Committee and science and Technology Bureau","award":["2023ZDXM026"],"award-info":[{"award-number":["2023ZDXM026"]}]},{"name":"Young and Middle-aged Medical Excellence Team Program of Chongqing","award":["2022"],"award-info":[{"award-number":["2022"]}]},{"name":"Chongqing Chief Expert Studio program","award":["2022"],"award-info":[{"award-number":["2022"]}]},{"name":"Innovation for Health Rare Disease Research Fund","award":["20250323"],"award-info":[{"award-number":["20250323"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-026-03747-w","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:04:28Z","timestamp":1771466668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Monocyte-macrophage SAMHD1 alleviates EAMG by modulating the cGAS-STING pathway"],"prefix":"10.1186","volume":"23","author":[{"given":"Wenjun","family":"Que","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingyang","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoqi","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5981-2922","authenticated-orcid":false,"given":"Fei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"1","key":"3747_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","volume":"5","author":"NE Gilhus","year":"2019","unstructured":"Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, et al. Myasthenia gravis. Nat Rev Dis Primers. 2019;5(1):30.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"3747_CR2","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","volume":"96","author":"P Narayanaswami","year":"2021","unstructured":"Narayanaswami P, Sanders DB, Wolfe G, et al. International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update. Neurology. 2021;96(3):114\u201322.","journal-title":"Neurology"},{"key":"3747_CR3","first-page":"100063","volume":"5","author":"J Chen","year":"2020","unstructured":"Chen J, Tian DC, Zhang C, et al. Incidence, mortality, and economic burden of myasthenia gravis in China: A nationwide population-based study. Lancet Reg Health West Pac. 2020;5:100063.","journal-title":"Lancet Reg Health West Pac"},{"issue":"7","key":"3747_CR4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1080\/14737175.2018.1491310","volume":"18","author":"S Wang","year":"2018","unstructured":"Wang S, Breskovska I, Gandhy S, Punga AR, Guptill JT, et al. Advances in autoimmune myasthenia gravis management. Expert Rev Neurother. 2018;18(7):573\u201388.","journal-title":"Expert Rev Neurother"},{"key":"3747_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jaut.2013.12.015","volume":"52","author":"A Gradolatto","year":"2014","unstructured":"Gradolatto A, Nazzal D, Truffault F, Bismuth J, Fadel E, et al. Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: Roles of IL-17 and TNFalpha. J Autoimmun. 2014;52:53\u201363.","journal-title":"J Autoimmun"},{"issue":"3","key":"3747_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3233\/JND-170294","volume":"5","author":"A Behin","year":"2018","unstructured":"Behin A, Le Panse R. New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis. J Neuromuscul Dis. 2018;5(3):265\u201377.","journal-title":"J Neuromuscul Dis"},{"key":"3747_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.clim.2017.08.008","volume":"183","author":"M Luo","year":"2017","unstructured":"Luo M, Liu X, Meng H, et al. IFNA-AS1 regulates CD4\u2009+\u2009T cell activation in myasthenia gravis though HLA-DRB1. Clin Immunol. 2017;183:121\u201331.","journal-title":"Clin Immunol"},{"issue":"6","key":"3747_CR8","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00401-021-02299-y","volume":"141","author":"F Ingelfinger","year":"2021","unstructured":"Ingelfinger F, Krishnarajah S, Kramer M, Utz SG, Galli E, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141(6):901\u201315.","journal-title":"Acta Neuropathol"},{"issue":"32","key":"3747_CR9","doi-asserted-by":"publisher","first-page":"14292","DOI":"10.1073\/pnas.1009234107","volume":"107","author":"M Mitsdoerffer","year":"2010","unstructured":"Mitsdoerffer M, Lee Y, J\u00e4ger A, Kim HJ, Korn T, et al. Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci U S A. 2010;107(32):14292\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3747_CR10","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/eji.201445064","volume":"45","author":"H Schaffert","year":"2015","unstructured":"Schaffert H, Pelz A, Saxena A, Losen M, Meisel A, et al. IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis. Eur J Immunol. 2015;45(5):1339\u201347.","journal-title":"Eur J Immunol"},{"key":"3747_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1196\/annals.1254.032","volume":"998","author":"M Milani","year":"2003","unstructured":"Milani M, Ostlie N, Wang W, Conti-Fine BM. T cells and cytokines in the pathogenesis of acquired myasthenia gravis. Ann N Y Acad Sci. 2003;998:284\u2013307.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"3747_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1365-3083.2012.02703.x","volume":"76","author":"Z Wang","year":"2012","unstructured":"Wang Z, Wang W, Chen Y, Wei D. T helper type 17 cells expand in patients with myasthenia-associated thymoma. Scand J Immunol. 2012;76(1):54\u201361.","journal-title":"Scand J Immunol"},{"issue":"1","key":"3747_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/nyas.13591","volume":"1413","author":"JA Villegas","year":"2018","unstructured":"Villegas JA, Van Wassenhove J, Le Panse R, Berrih-Aknin S, Dragin N. An imbalance between regulatory T cells and T helper 17 cells in acetylcholine receptor-positive myasthenia gravis patients. Ann N Y Acad Sci. 2018;1413(1):154\u201362.","journal-title":"Ann N Y Acad Sci"},{"key":"3747_CR14","doi-asserted-by":"publisher","first-page":"1083218","DOI":"10.3389\/fimmu.2023.1083218","volume":"14","author":"J Verdier","year":"2023","unstructured":"Verdier J, Fayet OM, Hemery E, Truffault F, Pinz\u00f3n N, et al. Single-cell mass cytometry on peripheral cells in Myasthenia Gravis identifies dysregulation of innate immune cells. Front Immunol. 2023;14:1083218.","journal-title":"Front Immunol"},{"issue":"4","key":"3747_CR15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/ana.26590","volume":"93","author":"CA Payet","year":"2023","unstructured":"Payet CA, You A, Fayet OM, Hemery E, Truffault F, et al. Central Role of Macrophages and Nucleic Acid Release in Myasthenia Gravis Thymus. Ann Neurol. 2023;93(4):643\u201354.","journal-title":"Ann Neurol"},{"issue":"1","key":"3747_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41421-021-00314-w","volume":"7","author":"W Jin","year":"2021","unstructured":"Jin W, Yang Q, Peng Y, et al. Single-cell RNA-Seq reveals transcriptional heterogeneity and immune subtypes associated with disease activity in human myasthenia gravis. Cell Discov. 2021;7(1):85.","journal-title":"Cell Discov"},{"key":"3747_CR17","doi-asserted-by":"publisher","first-page":"109184","DOI":"10.1016\/j.clim.2022.109184","volume":"245","author":"R Fan","year":"2022","unstructured":"Fan R, Que W, Liu Z, Zheng W, Guo X, et al. Single-cell mapping reveals dysregulation of immune cell populations and VISTA+ monocytes in myasthenia gravis. Clin Immunol. 2022;245:109184.","journal-title":"Clin Immunol"},{"issue":"7","key":"3747_CR18","doi-asserted-by":"publisher","first-page":"104925","DOI":"10.1016\/j.jbc.2023.104925","volume":"299","author":"CE Espada","year":"2023","unstructured":"Espada CE, Sari L, Cahill MP, Yang H, Phillips S, et al. SAMHD1 impairs type I interferon induction through the MAVS, IKK\u03b5, and IRF7 signaling axis during viral infection. J Biol Chem. 2023;299(7):104925.","journal-title":"J Biol Chem"},{"issue":"3","key":"3747_CR19","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1136\/annrheumdis-2013-204845","volume":"74","author":"S Kretschmer","year":"2015","unstructured":"Kretschmer S, Wolf C, K\u00f6nig N, Staroske W, Guck J, et al. SAMHD1 prevents autoimmunity by maintaining genome stability. Ann Rheum Dis. 2015;74(3):e17.","journal-title":"Ann Rheum Dis"},{"issue":"7703","key":"3747_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41586-018-0050-1","volume":"557","author":"F Coquel","year":"2018","unstructured":"Coquel F, Silva MJ, T\u00e9cher H, Zadorozhny K, Sharma S, et al. SAMHD1 acts at stalled replication forks to prevent interferon induction. Nature. 2018;557(7703):57\u201361.","journal-title":"Nature"},{"issue":"4","key":"3747_CR21","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3390\/v12040382","volume":"12","author":"SA Coggins","year":"2020","unstructured":"Coggins SA, Mahboubi B, Schinazi RF, Kim B. SAMHD1 Functions and Human Diseases. Viruses. 2020;12(4):382.","journal-title":"Viruses"},{"key":"3747_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.expneurol.2015.03.010","volume":"270","author":"M Losen","year":"2015","unstructured":"Losen M, Martinez-Martinez P, Molenaar PC, Lazaridis K, Tzartos S, et al. Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors\u2014Recommendations for methods and experimental designs. Exp Neurol. 2015;270:18\u201328.","journal-title":"Exp Neurol"},{"key":"3747_CR23","doi-asserted-by":"publisher","first-page":"107434","DOI":"10.1016\/j.intimp.2021.107434","volume":"93","author":"H Huang","year":"2021","unstructured":"Huang H, Ran H, Liu X, Yu L, Qiu L, et al. Leflunomide ameliorates experimental autoimmune myasthenia gravis by regulating humoral and cellular immune responses. Int Immunopharmacol. 2021;93:107434.","journal-title":"Int Immunopharmacol"},{"key":"3747_CR24","doi-asserted-by":"publisher","unstructured":"Wu B, Goluszko E, Huda R, T\u00fcz\u00fcn E, Christadoss P. Experimental autoimmune myasthenia gravis in the mouse. Curr Protoc Immunol. 2013;Chap. 15:Unit 15.8.. https:\/\/doi.org\/10.1002\/0471142735.im1508s100.","DOI":"10.1002\/0471142735.im1508s100"},{"issue":"4","key":"3747_CR25","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41590-022-01160-y","volume":"23","author":"S Tahtinen","year":"2022","unstructured":"Tahtinen S, Tong AJ, Himmels P, Oh J, Paler-Martinez A, et al. IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines. Nat Immunol. 2022;23(4):532\u201342.","journal-title":"Nat Immunol"},{"issue":"1","key":"3747_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/cei\/uxac013","volume":"208","author":"E Berenice Mart\u00ednez-Shio","year":"2022","unstructured":"Berenice Mart\u00ednez-Shio E, Mart\u00edn C\u00e1rdenas-Hern\u00e1ndez \u00c1, Jim\u00e9nez-Su\u00e1rez V, Sherell Mar\u00edn-J\u00e1uregui L, Del Castillo-Martin C, et al. Differentiation of circulating monocytes into macrophages with metabolically activated phenotype regulates inflammation in dyslipidemia patients. Clin Exp Immunol. 2022;208(1):83\u201394.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"3747_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ni.2236","volume":"13","author":"H Lahouassa","year":"2012","unstructured":"Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol. 2012;13(3):223\u20138.","journal-title":"Nat Immunol"},{"key":"3747_CR28","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.2147\/IJN.S192113","volume":"14","author":"A Rafique","year":"2019","unstructured":"Rafique A, Etzerodt A, Graversen JH, Moestrup SK, Dagn\u00e6s-Hansen F, et al. Targeted lipid nanoparticle delivery of calcitriol to human monocyte-derived macrophages in vitro and in vivo: investigation of the anti-inflammatory effects of calcitriol. Int J Nanomed. 2019;14:2829\u201346.","journal-title":"Int J Nanomed"},{"key":"3747_CR29","unstructured":"Zhang X, Goncalves R, Mosser DM. The isolation and characterization of murine macrophages. Curr Protoc Immunol. 2008;Chap. 14:14.1.1\u201314.1.14."},{"key":"3747_CR30","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.3389\/fimmu.2018.01186","volume":"9","author":"C Perrotta","year":"2018","unstructured":"Perrotta C, Cervia D, Di Renzo I, Moscheni C, Bassi MT, et al. Nitric Oxide Generated by Tumor-Associated Macrophages Is Responsible for Cancer Resistance to Cisplatin and Correlated With Syntaxin 4 and Acid Sphingomyelinase Inhibition. Front Immunol. 2018;9:1186.","journal-title":"Front Immunol"},{"issue":"1","key":"3747_CR31","doi-asserted-by":"publisher","first-page":"1774281","DOI":"10.1080\/2162402X.2020.1774281","volume":"9","author":"Y He","year":"2020","unstructured":"He Y, Du J, Dong Z. Myeloid deletion of phosphoinositide-dependent kinase-1 enhances NK cell-mediated antitumor immunity by mediating macrophage polarization. Oncoimmunology. 2020;9(1):1774281.","journal-title":"Oncoimmunology"},{"issue":"10","key":"3747_CR32","doi-asserted-by":"publisher","first-page":"e76943","DOI":"10.1371\/journal.pone.0076943","volume":"8","author":"S Ito","year":"2013","unstructured":"Ito S, Tanaka Y, Nishio N, Thanasegaran S, Isobe K. Establishment of self-renewable GM-CSF-dependent immature macrophages in vitro from murine bone marrow. PLoS ONE. 2013;8(10):e76943.","journal-title":"PLoS ONE"},{"issue":"12","key":"3747_CR33","doi-asserted-by":"publisher","first-page":"e734","DOI":"10.1002\/iid3.734","volume":"10","author":"X Li","year":"2022","unstructured":"Li X, Jiang M, Chen X, et al. Etanercept alleviates psoriasis by reducing the Th17\/Treg ratio and promoting M2 polarization of macrophages. Immun Inflamm Dis. 2022;10(12):e734.","journal-title":"Immun Inflamm Dis"},{"key":"3747_CR34","doi-asserted-by":"publisher","first-page":"114915","DOI":"10.1016\/j.jep.2021.114915","volume":"287","author":"H Zhang","year":"2022","unstructured":"Zhang H, Zhao B, Wei H, et al. Cucurbitacin b controls M2 macrophage polarization to suppresses metastasis via targeting JAK-2\/STAT3 signalling pathway in colorectal cancer. J Ethnopharmacol. 2022;287:114915.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"3747_CR35","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/cei.13546","volume":"203","author":"A Uzawa","year":"2021","unstructured":"Uzawa A, Kuwabara S, Suzuki S, Imai T, Murai H, et al. Roles of cytokines and T cells in the pathogenesis of myasthenia gravis. Clin Exp Immunol. 2021;203(3):366\u201374.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"3747_CR36","doi-asserted-by":"publisher","first-page":"e945","DOI":"10.1212\/NXI.0000000000000945","volume":"8","author":"S Ashida","year":"2021","unstructured":"Ashida S, Ochi H, Hamatani M, Fujii C, Kimura K, et al. Immune Skew of Circulating Follicular Helper T Cells Associates With Myasthenia Gravis Severity. Neurol Neuroimmunol Neuroinflamm. 2021;8(2):e945.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"3747_CR37","doi-asserted-by":"publisher","first-page":"1280029","DOI":"10.3389\/fimmu.2024.1280029","volume":"15","author":"X Song","year":"2024","unstructured":"Song X, He Y, Huo Y, Jiang H, Yu Y, et al. Normalized circulating Tfh and Th17 associates with improvement in myasthenia gravis treated with ofatumumab. Front Immunol. 2024;15:1280029.","journal-title":"Front Immunol"},{"issue":"1","key":"3747_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12950-024-00422-w","volume":"21","author":"Z Li","year":"2024","unstructured":"Li Z, Liu H, Xie Q, et al. Macrophage involvement in idiopathic inflammatory myopathy: pathogenic mechanisms and therapeutic prospects. J Inflamm (Lond). 2024;21(1):48.","journal-title":"J Inflamm (Lond)"},{"issue":"9","key":"3747_CR39","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.autrev.2013.03.010","volume":"12","author":"P Cavalcante","year":"2013","unstructured":"Cavalcante P, Cufi P, Mantegazza R, et al. Etiology of myasthenia gravis: innate immunity signature in pathological thymus. Autoimmun Rev. 2013;12(9):863\u201374.","journal-title":"Autoimmun Rev"},{"key":"3747_CR40","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.autrev.2018.10.005","volume":"18","author":"E Toubi","year":"2019","unstructured":"Toubi E, Vadasz Z. Innate immune-responses and their role in driving autoimmunity. Autoimmun Rev. 2019;18:306\u201311.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"3747_CR41","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1042\/BST20180348","volume":"47","author":"ER Morris","year":"2019","unstructured":"Morris ER, Taylor IA. The missing link: allostery and catalysis in the anti-viral protein SAMHD1. Biochem Soc Trans. 2019;47(4):1013\u201327.","journal-title":"Biochem Soc Trans"},{"issue":"7","key":"3747_CR42","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/ng.373","volume":"41","author":"GI Rice","year":"2009","unstructured":"Rice GI, Bond J, Asipu A, et al. Mutations involved in Aicardi-Gouti\u00e8res syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet. 2009;41(7):829\u201332.","journal-title":"Nat Genet"},{"key":"3747_CR43","doi-asserted-by":"publisher","unstructured":"Rui K, Chen Z, Liu J, Huang W, Wang X, et al. MDSC-derived IFN-\u03b2 promotes T follicular helper cell response and exacerbates lupus development. Arthritis Rheumatol. 2025. https:\/\/doi.org\/10.1002\/art.70004. Epub ahead of print.","DOI":"10.1002\/art.70004"},{"key":"3747_CR44","doi-asserted-by":"publisher","first-page":"106541","DOI":"10.1016\/j.intimp.2020.106541","volume":"84","author":"L Guo","year":"2020","unstructured":"Guo L, Lai P, Wang Y, Huang T, Chen X, et al. Extracellular vesicles derived from mesenchymal stem cells prevent skin fibrosis in the cGVHD mouse model by suppressing the activation of macrophages and B cells immune response. Int Immunopharmacol. 2020;84:106541.","journal-title":"Int Immunopharmacol"},{"issue":"16","key":"3747_CR45","doi-asserted-by":"publisher","first-page":"e108293","DOI":"10.15252\/embj.2021108293","volume":"40","author":"CC de Oliveira Mann","year":"2021","unstructured":"de Oliveira Mann CC, Hopfner KP. Nuclear cGAS: guard or prisoner? EMBO J. 2021;40(16):e108293.","journal-title":"EMBO J"},{"key":"3747_CR46","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1136\/annrheumdis-2018-212988","volume":"77","author":"Y Kato","year":"2018","unstructured":"Kato Y, Park J, Takamatsu H, et al. Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus. Ann Rheum Dis. 2018;77:1507\u201315.","journal-title":"Ann Rheum Dis"},{"issue":"24","key":"3747_CR47","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1111\/bph.15673","volume":"178","author":"Y Pan","year":"2021","unstructured":"Pan Y, You Y, Sun L, et al. The STING antagonist H-151 ameliorates psoriasis via suppression of STING\/NF-kappaB-mediated inflammation. Br J Pharmacol. 2021;178(24):4907\u201322.","journal-title":"Br J Pharmacol"},{"issue":"5","key":"3747_CR48","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s11064-025-04529-1","volume":"50","author":"W Shao","year":"2025","unstructured":"Shao W, Huo X, Liu X, et al. Dual Targeting of TLR9 and cGAS-STING Pathways Attenuates Astrocyte Inflammatory Activation: Potential Implication in Multiple Sclerosis. Neurochem Res. 2025;50(5):288.","journal-title":"Neurochem Res"},{"issue":"1","key":"3747_CR49","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/imr.13331","volume":"323","author":"MD Ah Kioon","year":"2024","unstructured":"Ah Kioon MD, Laurent P, Chaudhary V, et al. Modulation of plasmacytoid dendritic cells response in inflammation and autoimmunity. Immunol Rev. 2024;323(1):241\u201356.","journal-title":"Immunol Rev"},{"key":"3747_CR50","doi-asserted-by":"publisher","first-page":"1624957","DOI":"10.3389\/fimmu.2025.1624957","volume":"16","author":"X Zheng","year":"2025","unstructured":"Zheng X, Li L, Ma H, et al. Toll-like receptors and their role in the pathogenesis of myasthenia gravis: a comprehensive review. Front Immunol. 2025;16:1624957.","journal-title":"Front Immunol"},{"issue":"7","key":"3747_CR51","first-page":"1218","volume":"11","author":"CA Payet","year":"2022","unstructured":"Payet CA, You A, Fayet OM, et al. Myasthenia Gravis: Acquir Interferonopathy? Cells. 2022;11(7):1218.","journal-title":"Myasthenia Gravis: Acquir Interferonopathy? Cells"},{"issue":"5","key":"3747_CR52","doi-asserted-by":"publisher","first-page":"102800","DOI":"10.1016\/j.autrev.2021.102800","volume":"20","author":"R Zhao","year":"2021","unstructured":"Zhao R, Luo S, Zhao C. The role of innate immunity in myasthenia gravis. Autoimmun Rev. 2021;20(5):102800.","journal-title":"Autoimmun Rev"},{"key":"3747_CR53","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3389\/fimmu.2019.01140","volume":"10","author":"WT Ma","year":"2019","unstructured":"Ma WT, Gao F, Gu K, Chen DK. The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review. Front Immunol. 2019;10:1140.","journal-title":"Front Immunol"},{"key":"3747_CR54","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jaut.2017.05.005","volume":"82","author":"S Mamrut","year":"2017","unstructured":"Mamrut S, Avidan N, Truffault F, Staun-Ram E, Sharshar T, et al. Methylome and transcriptome profiling in Myasthenia Gravis monozygotic twins. J Autoimmun. 2017;82:62\u201373.","journal-title":"J Autoimmun"},{"key":"3747_CR55","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1212\/WNL.0000000000003697","volume":"88","author":"N Molko","year":"2017","unstructured":"Molko N, Simon O, Guyon D, et al. Zika virus infection and myasthenia gravis: report of 2 cases. Neurology. 2017;88:1097\u20138.","journal-title":"Neurology"},{"issue":"8","key":"3747_CR56","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1007\/s00415-020-10263-1","volume":"268","author":"S Sriwastava","year":"2021","unstructured":"Sriwastava S, Tandon M, Kataria S, et al. New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review. J Neurol. 2021;268(8):2690\u20136.","journal-title":"J Neurol"},{"key":"3747_CR57","doi-asserted-by":"publisher","first-page":"8489251","DOI":"10.1155\/2016\/8489251","volume":"2016","author":"X Fan","year":"2016","unstructured":"Fan X, Zhang H, Cheng Y, Jiang X, Zhu J, et al. Double Roles of Macrophages in Human Neuroimmune Diseases and Their Animal Models. Mediators Inflamm. 2016;2016:8489251.","journal-title":"Mediators Inflamm"},{"key":"3747_CR58","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1742-2094-8-58","volume":"8","author":"EJ Vereyken","year":"2011","unstructured":"Vereyken EJ, Heijnen PD, Baron W, de Vries EH, Dijkstra CD, et al. Classically and alternatively activated bone marrow derived macrophages differ in cytoskeletal functions and migration towards specific CNS cell types. J Neuroinflammation. 2011;8:58.","journal-title":"J Neuroinflammation"},{"key":"3747_CR59","doi-asserted-by":"crossref","unstructured":"Rogers BM, Smith L, Dezso Z, et al. VISTA is an activating receptor in human monocytes. J Exp Med. 2021;218(8):e20201601.","DOI":"10.1084\/jem.20201601"},{"issue":"5","key":"3747_CR60","doi-asserted-by":"publisher","first-page":"e26741","DOI":"10.1016\/j.heliyon.2024.e26741","volume":"10","author":"J Dong","year":"2024","unstructured":"Dong J, Duan RS, Zhang P. Causal relationship between the immune phenotype of monocytes and myasthenia gravis: A Mendelian randomization study. Heliyon. 2024;10(5):e26741.","journal-title":"Heliyon"},{"key":"3747_CR61","doi-asserted-by":"publisher","first-page":"102382","DOI":"10.1016\/j.jaut.2019.102382","volume":"110","author":"V Saferding","year":"2020","unstructured":"Saferding V, Bl\u00fcml S. Innate immunity as the trigger of systemic autoimmune diseases. J Autoimmun. 2020;110:102382.","journal-title":"J Autoimmun"},{"issue":"1","key":"3747_CR62","doi-asserted-by":"publisher","first-page":"102430","DOI":"10.1016\/j.autrev.2019.102430","volume":"19","author":"NJ Wasko","year":"2020","unstructured":"Wasko NJ, Nichols F, Clark RB, et al. Multiple sclerosis, the microbiome, TLR2, and the hygiene hypothesis. Autoimmun Rev. 2020;19(1):102430.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"3747_CR63","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/(SICI)1097-4598(200006)23:6<946::AID-MUS16>3.0.CO;2-4","volume":"23","author":"N Teleshova","year":"2000","unstructured":"Teleshova N, Matusevicius D, Kivis\u00e4kk P, Mustafa M, Pirskanen R, et al. Altered expression of costimulatory molecules in myasthenia gravis. Muscle Nerve. 2000;23(6):946\u201353.","journal-title":"Muscle Nerve"},{"issue":"2","key":"3747_CR64","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0165-5728(94)90044-2","volume":"50","author":"Q Yi","year":"1994","unstructured":"Yi Q, Ahlberg R, Pirskanen R, Lefvert AK. Acetylcholine receptor-reactive T cells in myasthenia gravis: evidence for the involvement of different subpopulations of T helper cells. J Neuroimmunol. 1994;50(2):177\u201386.","journal-title":"J Neuroimmunol"},{"issue":"3\u20134","key":"3747_CR65","first-page":"229","volume":"455","author":"JL Wang","year":"2014","unstructured":"Wang JL, Lu FZ, Shen XY, Wu Y, Zhao LT. SAMHD1 is down regulated in lung cancer by methylation and inhibits tumor cell proliferation. Biochem Biophys Res Commun. 2014;455(3\u20134):229\u201333.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3747_CR66","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s42003-020-1052-8","volume":"3","author":"T Rothenburger","year":"2020","unstructured":"Rothenburger T, McLaughlin KM, Herold T, Schneider C, Oellerich T, et al. SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabine. Commun Biol. 2020;3(1):324.","journal-title":"Commun Biol"},{"issue":"6\u20137","key":"3747_CR67","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s10571-009-9367-5","volume":"29","author":"O Bugos","year":"2009","unstructured":"Bugos O, Bhide M, Zilka N. Beyond the rat models of human neurodegenerative disorders. Cell Mol Neurobiol. 2009;29(6\u20137):859\u201369.","journal-title":"Cell Mol Neurobiol"},{"issue":"11","key":"3747_CR68","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/nm.2224","volume":"16","author":"M Jucker","year":"2010","unstructured":"Jucker M. The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nat Med. 2010;16(11):1210\u20134.","journal-title":"Nat Med"},{"key":"3747_CR69","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/bs.irn.2025.04.029","volume":"182","author":"PM Sikorski","year":"2025","unstructured":"Sikorski PM, Kusner LL. Animal models of myasthenia gravis. Int Rev Neurobiol. 2025;182:145\u201360.","journal-title":"Int Rev Neurobiol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03747-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03747-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03747-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:04:10Z","timestamp":1774523050000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03747-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3747"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03747-w","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"13 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study performed was approved by the Ethical Committee of the First Affiliated Hospital of Chongqing Medical University (Approval No. 2020\u2009\u2212\u2009382), and written informed consent was obtained from all participants. The animal experiments in this study were approved by the Animal Experiments Ethical Committee of Chongqing Medical University (IACUC-CQMU-2024-0484).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}